Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MrMed is an India-based online specialty pharmacy platform that focuses on providing affordable and accessible super-specialty medicines for life-threatening conditions. The company specializes in high-value medications for therapeutic areas such as oncology, nephrology, hepatology, and rare diseases, often offering significant discounts compared to traditional retail prices. Beyond medicine delivery, MrMed provides patient support services, including assistance with financial aid programs and diagnostic tests. By leveraging a robust supply chain and digital infrastructure, the company aims to bridge the gap in the availability of critical care drugs across India. Their business model emphasizes transparency, authenticity, and timely delivery to patients dealing with chronic and complex health issues.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MrMed.